NCT05992623Completed
Clinical Trial Comparing Devices Used for Cardioversion of Atrial Fibrillation
A Pragmatic Randomized Clinical Trial Comparing Rectilinear Biphasic Waveform and Biphasic Truncated Exponential Waveform Shocks for Cardioversion of Atrial Fibrillation (Zoll vs Lifepak)
Source: ClinicalTrials.gov · Last updated 22 Sept 2025
Brief summary (registry, in English)
The goal of this single center, investigator initiated, open label prospective randomized controlled trial is to compare the efficacy of a single 200J RBW shock and a single 360J BTE shock. The secondary objective of the study is to compare the frequency of adverse events after one or two 200J RBW or 360J BTE shocks
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 546 (actual)
- First submitted
- 21 Jul 2023
- Start date
- 21 Jul 2023
- Primary completion date
- 14 Aug 2024
- Lead sponsor
- Inova Health Care Services
- Diseases
- Atrial fibrillation
- NCT number
- NCT05992623
What you commit to
- Study type: Interventional
- Participants enrolled: 546
- From 21 Jul 2023 to the primary completion date, 14 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants who are receiving any other investigational agents.
Other illness
- Patients with arrhythmias other than AF
Other
- Parents/guardians or participants who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
- Patients with hemodynamically unstable AF
- Patients with untreated hyperthyroidism
- Patients with known or suspected pregnancy
- Patients without sufficient anticoagulation or a transesophageal echocardiogram or computed tomography scan documenting the absence of intracardiac thrombi
Who the study is looking for
- Age ≥ 18 years
- In AF on presentation with plan for DCCV in either the Electrophysiology lab or DCCV procedure area
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Inova Health System Coordinator of this site? Confirm its status | Falls Church | United States | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.